Scientists test 'Booster Shot' to make Cancer-Fighting cells last longer
NCT ID NCT07052305
Summary
This early-stage study is testing whether a drug called NT-I7 can make CAR-T cell therapy work better for people with large B-cell lymphoma that has come back or hasn't responded to treatment. Researchers want to see if giving NT-I7 after standard CAR-T therapy is safe and if it helps the patient's own engineered immune cells grow stronger and fight the cancer for longer. The study will involve about 24 adults who are eligible for approved CAR-T treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.